We are “modeled” after US Research Sites, and our team consists of US Board Certified trained Investigators and experienced research staff. We have successfully conducted Phase I through Phase IV Clinical Trials and with our recent merger, we have substantially increased our scope with the ability to conduct a multitude of varied medically indicated Clinical Trials. We have conducted investigative new drug and investigative medical device trials. Our trials have been secured through large Pharmaceutical Companies, and small biotech firms, and CROs from the United States, Canada, and South American Regions. Our state-of-the-art facility has been designed specifically for the conduction of Clinical Trials.

Our location affords proximity to local hospitals, one of which is JCAHO-accredited. We are also conveniently located near the newly expanded Sir Lynden Pindling International Airport. This new airport (one of the very few worldwide) is equipped with US Immigration and Customs Clearance facilities, which provide expedited business travel. The airport accommodates frequent flights from various International regions and numerous cities in the United States. Our monitors find it convenient to travel for visits, oftentimes for one day, with no need to exchange currency. Our demographics include a population of over 375,000. The ethnicity is 85 % African descent, 3% Asian and Hispanic, and 12% Caucasian, with a high literacy rate. Most of the Bahamian population resides in the capital city, Nassau, on the Island of New Providence. The island is 22 miles long by 7 miles wide, creating a dense patient population base and providing easy access for our trial participants.

We are fortunate to have established a satisfied subject base and thus have enjoyed favorable community attitudes toward our research trials with patients that also have Medicare or Medicaid, and for older citizens, Medicaid currently offers incontinence supplies coverage in 45 states and more. Additionally, we have proven high compliance rates with our enrolled subjects and optimal subject retention. Our new facility is equipped with a full laboratory, compliant with CDC guidelines, a fully operating pharmacy, multiple full-time Investigators, an In-house Comprehensive Imaging Centre with CT capabilities, Nuclear Medicine, a Heart Centre with echocardiography and complete cardiac testing, a Cancer Centre accredited by the American College Radiation Oncology (ACRO), Chemo suites, and a Comprehensive Dialysis Centre.

Our vast local experience allows us to achieve fast turnaround times from feasibility to study start-up through successful trial completion. Our regulatory environment is streamlined by utilizing a Local Ethics Committee and a Central IRB for dual oversight. We are proficient in FDA regulations, adhere strictly to ICH GCP guidelines, and comply with local laws. We have established site-specific SOPs, which are reviewed and updated frequently.

Our investigators are US board certified in their specialties and, together with our US-trained full-time research staff, are well versed in the complexities of the conduction of trials, from start-up to completion.